PreciOnco

Clinical board

Precision Through Teamwork

At PreciOnco, each patient’s case is reviewed by an interdisciplinary medical board, ensuring that every aspect of care is carefully considered from multiple medical perspectives. During these meetings, the patient’s comprehensive genetic reports, immune monitoring results along with their medical history, are evaluated and discussed in detail, resulting in an individualized treatment plan. Medical boards are conducted together with the MVZ Tübingen team led by Dr. Saskia Biskup, a renowned human geneticist and co-founder of CeGat, ensuring that each patient benefits from world-class expertise in precision oncology.

Dr. Med. Dr. Rer. Nat. Saskia Biskup

Saskia Biskup, MD, PhD

Human Genetics
Saskia Biskup is a specialist in human genetics and founder of the Center for Human Genetics in Tübingen, as well as Managing Director of CeGaT GmbH. With dual doctorates in medicine and natural sciences, she brings extensive experience from both clinical and research settings, including international work at Johns Hopkins University. Her focus is on making cutting-edge genetic diagnostics accessible to patients, recognizing human genetics as a cornerstone of future precision medicine.
Dr. Olga Maksimovic

Olga Maksimovic, MD

Internal Medicine, Hematology and Oncology, and Palliative Medicine; Medical Director
Dr. Olga Maksimovic is a specialist in internal medicine with additional qualifications in hematology, oncology, and palliative care. She completed her medical training and doctorate in dermatologic oncology at the University Hospital Tübingen and has held senior positions in several oncology centers across Germany. Since July 2024, she has been part of the MVZ Tübingen team, where she brings extensive experience in comprehensive cancer and palliative care.
Dr. Veit Scheble

Veit Scheble, MD

Internal Medicine and Gastroenterology
Dr. Veit Scheble is a specialist in internal medicine and gastroenterology with a focus on gastrointestinal oncology. He studied at Friedrich Schiller University Jena and earned his doctorate at University Hospital Tübingen, where he later led key departments and coordinated the Center for GI Oncology. He has been part of the MVZ Tübingen team since October 2023.
Tomas Janušonis

Tomas Janušonis, MD, PhD

Managing Director
Dr. Tomas Janušonis is the Managing Director of PreciOnco Clinic and has over 20 years of experience as a medical doctor specializing in anesthesia and intensive care. He holds a PhD in clinical pharmacology and is actively involved in medical research and lectures at Vilnius University. With broad experience in both patient care and leadership roles in the pharmaceutical and clinical research fields, Dr. Janušonis brings together medical expertise and the latest scientific knowledge to provide safe, effective, and personalized care.